Emergence of ceftazidime/avibactam resistance in carbapenem-resistant Klebsiella pneumoniae in China

Yerel katalogda bu makaleye atıf yapan 17 yayın (OpenAlex referans eşleşmesi; tam dünya listesi değildir).

1. 2022 European Society of clinical microbiology and infectious diseases (ESCMID) guidelines for the treatment of infections caused by Multidrug-resistant Gram-negative bacilli (endorsed by ESICM \u2013European Society of intensive care Medicine)Atıf 1.079 · OpenAlex
2. 2025 Newly developed antibiotics against multidrug-resistant and carbapenem-resistant Gram-negative bacteria: action and resistance mechanismsAtıf 18 · OpenAlex
3. 2021 Ceftazidime-Avibactam susceptibility among carbapenem-resistant Enterobacterales in a pilot study in TurkeyAtıf 7 · OpenAlex
4. 2021 Ceftazidime - Avibactam susceptibility among carbapenem-resistant Enterobacterales in a pilot study in Turkey.Atıf 7 · OpenAlex
5. 2021 Ceftazidime \u2013 Avibactam susceptibility among carbapenem-resistant Enterobacterales in a pilot study in TurkeyAtıf 7 · OpenAlex
6. 2023 Investigation of in vitro efficacy of quercetin-meropenem combination in carbapenemase-producing Klebsiella pneumoniae isolatesAtıf 5 · OpenAlex
7. 2023 Investigation of in vitro efficacy of quercetin-meropenem combination in carbapenemase-producing Klebsiella pneumoniae isolatesAtıf 5 · OpenAlex
8. 2022 Investigation of ceftazidime-avibactam susceptibility in clinical isolates of gram-negative bacteriaAtıf 5 · OpenAlex
9. 2022 Investigation of ceftazidime-avibactam susceptibility in clinical isolates of gram-negative bacteriaAtıf 5 · OpenAlex
10. 2022 Investigation of ceftazidime-avibactam susceptibility in clinical isolates of gram-negative bacteriaAtıf 5 · OpenAlex